{"pmid":32354772,"title":"Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.","text":["Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.","Ann Rheum Dis","Duret, Pierre-Marie","Sebbag, Eden","Mallick, Auriane","Gravier, Simon","Spielmann, Lionel","Messer, Laurent","32354772"],"journal":"Ann Rheum Dis","authors":["Duret, Pierre-Marie","Sebbag, Eden","Mallick, Auriane","Gravier, Simon","Spielmann, Lionel","Messer, Laurent"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354772","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/annrheumdis-2020-217362","keywords":["antirheumatic agents","arthritis, infectious","biological therapy","spondylitis, ankylosing","tumour necrosis factor inhibitors"],"weight":0,"_version_":1666138495216779265,"score":9.490897,"similar":[{"pmid":32241793,"title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.","text":["Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.","Ann Rheum Dis","Monti, Sara","Balduzzi, Silvia","Delvino, Paolo","Bellis, Elisa","Quadrelli, Verdiana Serena","Montecucco, Carlomaurizio","32241793"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Balduzzi, Silvia","Delvino, Paolo","Bellis, Elisa","Quadrelli, Verdiana Serena","Montecucco, Carlomaurizio"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241793","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1136/annrheumdis-2020-217424","keywords":["antirheumatic agents","arthritis, rheumatoid","biological therapy","spondylitis, ankylosing"],"link_comment_in":"32299844","topics":["Treatment"],"weight":1,"_version_":1666138492152840194,"score":99.13433},{"pmid":32321720,"title":"Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).","text":["Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).","Ann Rheum Dis","Giollo, Alessandro","Adami, Giovanni","Gatti, Davide","Idolazzi, Luca","Rossini, Maurizio","32321720"],"journal":"Ann Rheum Dis","authors":["Giollo, Alessandro","Adami, Giovanni","Gatti, Davide","Idolazzi, Luca","Rossini, Maurizio"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321720","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1136/annrheumdis-2020-217598","keywords":["anti-inflammatory agents, non-steroidal","arthritis, psoriatic","arthritis, rheumatoid","biological therapy","spondylitis, ankylosing"],"topics":["Treatment"],"weight":1,"_version_":1666138493776035840,"score":64.73393},{"pmid":32414805,"title":"Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.","text":["Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.","Ann Rheum Dis","Monti, Sara","Montecucco, Carlomaurizio","32414805"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Montecucco, Carlomaurizio"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32414805","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1136/annrheumdis-2020-217738","keywords":["antirheumatic agents","arthritis","biological therapy"],"weight":0,"_version_":1666991242708254722,"score":59.58813},{"pmid":32299795,"title":"Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.","text":["Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.","Ann Rheum Dis","Gupta, Latika","Misra, Durga Prasanna","Agarwal, Vishwesh","Balan, Suma","Agarwal, Vikas","32299795"],"journal":"Ann Rheum Dis","authors":["Gupta, Latika","Misra, Durga Prasanna","Agarwal, Vishwesh","Balan, Suma","Agarwal, Vikas"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299795","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1136/annrheumdis-2020-217509","keywords":["antirheumatic agents","autoimmune diseases","biological therapy","communicable diseases, imported","glucocorticoids"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666138494849777664,"score":52.83024},{"pmid":32376597,"title":"Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.","text":["Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.","Ann Rheum Dis","Aouba, Achille","Baldolli, Aurelie","Geffray, Loik","Verdon, Renaud","Bergot, Emmanuel","Martin-Silva, Nicolas","Justet, Aurelien","32376597"],"journal":"Ann Rheum Dis","authors":["Aouba, Achille","Baldolli, Aurelie","Geffray, Loik","Verdon, Renaud","Bergot, Emmanuel","Martin-Silva, Nicolas","Justet, Aurelien"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376597","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1136/annrheumdis-2020-217706","keywords":["antirheumatic agents","biological therapy","cytokines","interleukin 1 receptor antagonist protein","therapeutics"],"topics":["Case Report"],"weight":1,"_version_":1666597097452863489,"score":52.83024}]}